Advertisement
UK markets close in 2 hours 50 minutes
  • FTSE 100

    7,959.02
    +27.04 (+0.34%)
     
  • FTSE 250

    19,870.73
    +60.07 (+0.30%)
     
  • AIM

    743.28
    +1.17 (+0.16%)
     
  • GBP/EUR

    1.1692
    +0.0023 (+0.20%)
     
  • GBP/USD

    1.2633
    -0.0005 (-0.04%)
     
  • Bitcoin GBP

    56,012.84
    -177.75 (-0.32%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,248.15
    -0.34 (-0.01%)
     
  • DOW

    39,784.46
    +24.38 (+0.06%)
     
  • CRUDE OIL

    82.49
    +1.14 (+1.40%)
     
  • GOLD FUTURES

    2,207.80
    +17.20 (+0.79%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,487.46
    +10.37 (+0.06%)
     
  • CAC 40

    8,221.03
    +16.22 (+0.20%)
     

US STOCKS-Wall Street steps back from record highs

* Energy shares surge on oil rally

* Drugmakers Bristol-Myers, Allergan (NYSE: AGN - news) , Merck (LSE: 0O14.L - news) drop

* Indexes down: Dow 0.2 pct, S&P 0.21 pct, Nasdaq (NasdaqGS: NDAQ - news) 0.34 pct (Updates to afternoon)

By Noel Randewich

Aug 8 (Reuters) - Wall Street retreated from record highs on Monday as a drop in healthcare stocks offset the impact of higher oil prices on energy stocks and a strong jobs report.

A rally to several all-time highs since late June has left the S&P 500 up nearly 7 percent in 2016, with many investors concerned about stretched valuations.

"This is a natural pause for reflection by the markets. Everyone is sitting there saying 'Holy cow, what did we do?'," said Brad McMillan, chief investment officer at Commonwealth Financial Network.

ADVERTISEMENT

"Momentum is a big part of it. People are afraid of missing out."

Pressured by losses in Bristol-Myers, Merck (Jakarta: 28586808.JK - news) and Allergan, the S&P 500 healthcare index dipped 1 percent while the Nasdaq biotech index dropped 1.2 percent.

Oil prices rose more than 2 percent after a report last week indicated that some OPEC members had called for a freeze in production.

Investors fretted about growing signs that S&P 500 aggregate earnings could decline for a sixth straight quarter.

Analysts polled by Reuters expect third-quarter earnings to fall 0.2 percent, as of Monday. They had estimated a 0.2 percent rise on Aug. 3.

At 2:32 pm EDT (1832 GMT), the Dow Jones industrial average was down 0.2 percent to 18,506.48 points and the S&P 500 dipped 0.21 percent to 2,178.31.

The Nasdaq Composite dropped 0.34 percent to 5,203.43.

Seven of the 10 major S&P 500 indexes fell, with the healthcare group losing the most. The energy index gained 1.45 percent, with Exxon Mobil (Swiss: XOM.SW - news) up 1.1 percent.

Bristol-Myers fell for the second straight day, shedding 4.6 percent after it said on Friday its lung-cancer drug failed a key late-stage study.

Merck, which makes a rival drug, fell 1.8 percent. The stock had rallied 10 percent on Friday.

Allergan lost 2.8 percent after it slashed its full-year revenue forecast and said it was not looking to use its surplus cash to fund any deals.

Advancing issues outnumbered declining ones on the New York Stock Exchange by a 1.35-to-1 ratio. On Nasdaq, a 1.18-to-1 ratio favored decliners.

The S&P 500 posted 29 new 52-week highs and no new lows. The Nasdaq Composite recorded 90 new highs and 13 new lows. (Reporting by Noel Randewich in New York; Additional reporting by Yashaswini Swamynathan in Bengaluru; Editing by Jeffrey Benkoe)